REATA PHARMACEUTICALS INC Accounts Receivable
REATA PHARMACEUTICALS INC had Accounts Receivable of $22.66 million as of 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2023-08-08
- 2023-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $22.66M.
- 2022-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $0.00.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2023-06-30 | $22.66M 10-Q · filed 2023-08-08 |
| 2022-12-31 | $0.00 10-Q · filed 2023-08-08 |